• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药品福利管理机构对社区药房的影响:一项范围综述。

The impact of pharmacy benefit managers on community pharmacy: A scoping review.

作者信息

Rosenthal Meagen, Miller Lindsey, Bateman Mixson, Smith Megan, Nueva Katrina, Ballou Jordan M

机构信息

Department of Pharmacy Administration, University of Mississippi School of Pharmacy, University, MS, United States of America.

Community-based Pharmacy Resident at Moose Pharmacy, The University of North Carolina Eshelman School of Pharmacy in Chapel Hill, NC, United States of America.

出版信息

Explor Res Clin Soc Pharm. 2023 May 27;10:100283. doi: 10.1016/j.rcsop.2023.100283. eCollection 2023 Jun.

DOI:10.1016/j.rcsop.2023.100283
PMID:37333968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10276176/
Abstract

INTRODUCTION

The introduction of pharmacy benefit managers (PBMs) within the United States healthcare system occurred with the aim to decrease costs and increase quality. News media and legislation have painted a picture of decreased pharmacy competition and potential negative impacts on patients and their access to affordable medications.

OBJECTIVE

The objective of this scoping review was to evaluate the current research literature examining the impact of PBMs on the finances of community pharmacies.

METHODS

Scientific journal articles published between 2010 and 2022 were included if they met the predefined objective.

RESULTS

This scoping review identified four articles that met inclusion criteria. None of the identified articles independently quantified the financial impact of PBMs on community pharmacies.

CONCLUSIONS

Additional research should be completed to specifically understand the financial impact on community pharmacies to help ensure the viability of community pharmacy as an integral access point for patients.

摘要

引言

美国医疗保健系统引入药房福利管理机构(PBMs)的目的是降低成本并提高质量。新闻媒体和立法描绘了一幅药房竞争减少以及对患者及其获得平价药物的机会可能产生负面影响的图景。

目的

本范围综述的目的是评估当前研究文献,以考察PBMs对社区药房财务状况的影响。

方法

如果符合预先设定的目标,则纳入2010年至2022年间发表的科学期刊文章。

结果

本范围综述确定了四篇符合纳入标准的文章。所确定的文章均未独立量化PBMs对社区药房的财务影响。

结论

应完成更多研究,以具体了解对社区药房的财务影响,从而有助于确保社区药房作为患者重要接入点的可行性。

相似文献

1
The impact of pharmacy benefit managers on community pharmacy: A scoping review.药品福利管理机构对社区药房的影响:一项范围综述。
Explor Res Clin Soc Pharm. 2023 May 27;10:100283. doi: 10.1016/j.rcsop.2023.100283. eCollection 2023 Jun.
2
Pharmacy Benefit Managers: History, Business Practices, Economics, and Policy.医药福利管理公司:历史、业务实践、经济学和政策。
JAMA Health Forum. 2023 Nov 3;4(11):e233804. doi: 10.1001/jamahealthforum.2023.3804.
3
State-level policy efforts to regulate pharmacy benefit managers (PBMs).州级层面规范药品福利管理机构的政策努力。
Res Social Adm Pharm. 2022 Nov;18(11):3995-4002. doi: 10.1016/j.sapharm.2022.07.045. Epub 2022 Jul 31.
4
Impact of Pharmacy Benefit Managers on Oncology Practices and Patients.医药福利管理对肿瘤学实践和患者的影响。
JCO Oncol Pract. 2020 May;16(5):276-284. doi: 10.1200/JOP.19.00606. Epub 2020 Apr 20.
5
Use of and Steering to Pharmacies Owned by Insurers and Pharmacy Benefit Managers in Medicare.医疗保险中对保险公司和药品福利管理机构所属药店的使用及引导情况。
JAMA Health Forum. 2025 Jan 3;6(1):e244874. doi: 10.1001/jamahealthforum.2024.4874.
6
Through the lens of rural patients and pharmacies: A content analysis of state level pharmacy benefit manager regulations and policies.从农村患者和药房的视角:对州级药房福利管理法规和政策的内容分析。
Explor Res Clin Soc Pharm. 2025 Mar 25;18:100595. doi: 10.1016/j.rcsop.2025.100595. eCollection 2025 Jun.
7
Medication review service implementation in community pharmacy settings: Scoping review with focus on implementation studies.社区药房中药物审查服务的实施:以实施研究为重点的范围综述。
Res Social Adm Pharm. 2020 Jul;16(7):875-885. doi: 10.1016/j.sapharm.2019.10.005. Epub 2019 Oct 7.
8
Facilitators and barriers to community pharmacy PrEP delivery: a scoping review.促进和阻碍社区药房提供 PrEP 的因素:范围综述。
J Int AIDS Soc. 2024 Mar;27(3):e26232. doi: 10.1002/jia2.26232.
9
Emerging trends in cancer care: health plans' and pharmacy benefit managers' perspectives on changing care models.癌症护理的新趋势:健康计划和药房福利管理者对不断变化的护理模式的看法。
Am Health Drug Benefits. 2012 Jul;5(4):242-53.
10
Pharmacy Deserts and Pharmacies' Roles Post-Extreme Weather and Climate Events in the United States: A Scoping Review.美国极端天气和气候事件后的“药店荒漠”与药店角色:范围综述。
J Prim Care Community Health. 2023 Jan-Dec;14:21501319231186497. doi: 10.1177/21501319231186497.

引用本文的文献

1
Through the lens of rural patients and pharmacies: A content analysis of state level pharmacy benefit manager regulations and policies.从农村患者和药房的视角:对州级药房福利管理法规和政策的内容分析。
Explor Res Clin Soc Pharm. 2025 Mar 25;18:100595. doi: 10.1016/j.rcsop.2025.100595. eCollection 2025 Jun.
2
Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model.通用心脏病药物价格:马克·库班成本加成制药公司模式的潜在益处
Front Pharmacol. 2023 Aug 22;14:1179253. doi: 10.3389/fphar.2023.1179253. eCollection 2023.

本文引用的文献

1
State-level policy efforts to regulate pharmacy benefit managers (PBMs).州级层面规范药品福利管理机构的政策努力。
Res Social Adm Pharm. 2022 Nov;18(11):3995-4002. doi: 10.1016/j.sapharm.2022.07.045. Epub 2022 Jul 31.
2
Impact of Pharmacy Benefit Managers on Oncology Practices and Patients.医药福利管理对肿瘤学实践和患者的影响。
JCO Oncol Pract. 2020 May;16(5):276-284. doi: 10.1200/JOP.19.00606. Epub 2020 Apr 20.
3
Evaluation of the economic and clinical impact of community pharmacist-driven pharmacy benefit management services.
评价社区药剂师主导的药品福利管理服务的经济和临床影响。
J Am Pharm Assoc (2003). 2019 Jul-Aug;59(4S):S91-S94. doi: 10.1016/j.japh.2019.03.016. Epub 2019 Jun 13.
4
The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians.美国医药市场中药房福利管理(PBM)与疗法费用之间的关系:临床医生的政策入门。
Am Heart J. 2018 Dec;206:113-122. doi: 10.1016/j.ahj.2018.08.006. Epub 2018 Aug 23.
5
Direct and Indirect Remuneration Fees: The Controversy Continues.直接和间接薪酬费用:争议仍在继续。
Hosp Pharm. 2017 Dec;52(11):740-741. doi: 10.1177/0018578717739633. Epub 2017 Nov 9.
6
Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor Therapy.预先授权和自付费用与患者获得 PCSK9 抑制剂治疗的关联。
JAMA Cardiol. 2017 Nov 1;2(11):1217-1225. doi: 10.1001/jamacardio.2017.3451.
7
Exposing some important barriers to health care access in the rural USA.揭示美国农村地区医疗保健获取的一些重要障碍。
Public Health. 2015 Jun;129(6):611-20. doi: 10.1016/j.puhe.2015.04.001. Epub 2015 May 27.
8
Squeezing the middleman: ending underhanded dealing in the pharmacy benefit management industry through regulation.挤压中间人:通过监管终结药品福利管理行业的不正当交易。
Ann Health Law. 2011 Winter;20(1):77-112, 7 p preceding 1.
9
Economic impact of pharmacist-reimbursed drug therapy modification.药师报销的药物治疗修改的经济影响。
J Am Pharm Assoc (2003). 2011 Jan-Feb;51(1):58-64. doi: 10.1331/JAPhA.2011.09115.
10
Primary care: current problems and proposed solutions.基层医疗保健:当前问题与解决方案。
Health Aff (Millwood). 2010 May;29(5):799-805. doi: 10.1377/hlthaff.2010.0026.